AJ303
Idiopathic pulmonary fibrosis and other organ fibrosis
PreclinicalActive
Key Facts
Indication
Idiopathic pulmonary fibrosis and other organ fibrosis
Phase
Preclinical
Status
Active
Company
About AnnJi Pharmaceutical
Taiwan biotech developing first‑in‑class small‑molecule therapies for neurology, immunology and fibrosis.
View full company profile